samedan logo
 
 
spacer
home > epc > autumn 2006 > inwardly mobile
PUBLICATIONS
European Pharmaceutical Contractor

Inwardly Mobile

Building successful recruitment and retention strategies is vital to the enhancement of organisational productivity across the pharmaceutical industry. Jo Causon of the Chartered Management Institute identifies the challenges ahead

In a highly competitive job market, recruiting and retaining high performing managers at all levels of the organisation has become an increasingly important issue for pharmaceutical businesses. To attract staff and encourage continued engagement, organisations are under greater pressure to offer more opportunities internally. Many consider recruitment and retention as the remit of HR; however all managers need to understand their role in staff retention and the action they need to take.

The reason for this is clear, as findings from this year’s National Management Salary Survey suggest. Published by the Chartered Management Institute and Remuneration Economics, the research shows that in most business sectors, resignations have increased because of employee frustration with company pay structures and a lack of job satisfaction. However, the research has revealed an interesting difference with organisations in the pharmaceutical sector; people are changing roles internally more frequently, perhaps suggesting that they are happy to seek new challenges with their current employers. This could also suggest that, rather than looking to other organisations, they are finding what they want by working with their employers to identify different opportunities.

EMPLOYMENT AND THE PHARMA INDUSTRY

Within such a highly competitive environment, where many individuals are working on areas of projects alone or in small groups, pharmaceutical companies appear to be working hard to keep their talented workforce. In fact, for the 12 months to January 2006, pharmaceutical organisations reported a labour turnover rate of 16.9 per cent; of this, 13.9 per cent results from internal transfers. The remaining three per cent accounts for resignations, redundancies, retirements and other reasons. This shows that managers in the pharmaceutical industry resign less often than those in other business areas (1.5 per cent compared to 4.6 per cent across all industries). Perhaps we can conclude, then, that the industry is leading the way in terms of career opportunities for individuals who wish to progress through their organisations.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
As the Director of Marketing and Corporate Affairs at the Chartered Management Institute, Jo Causon is responsible for the strategic development of the Institute’s brand and for building partnerships and networks that influence policy development and address the issues that matter to employers and individual managers. She has been Head of Group Marketing at City & Guilds, where she delivered a strategy to reposition the corporate brand and their diverse portfolio of products and services. Before her three years at City & Guilds, Jo was Head of Brand at Norwich Union, where she was responsible for developing both the corporate brand and supporting sub brands.
spacer
Jo Causon
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Inaugural Conference on Pre-Filled Syringes

21-22 January 2009, Crowne Plaza Hotel - St James, London, UK

SMi present their Inaugural Conference on Pre-Filled Syringes 21st and 22nd January 2009 at the Crowne Plaza Hotel - St James, London, UK
More info >>

 
News and Press Releases

Azopharma Product Development Group, Inc

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement